Americans now have widespread access to two vaccines that offer protection against COVID-19, with a third — the single-dose Johnson & Johnson vaccine approved by the FDA on February 27 — expected to reach providers in the coming weeks.
As soon as the scale and seriousness of the COVID-19 pandemic became clear in early 2020, talk began to focus on the challenges of developing vaccines. The past year has seen an unprecedented effort to develop and deploy safe and effective vaccines to control a virus that has now claimed 2.5 million lives worldwide — and more than 500,000 in the U.S. alone.
At eClinicalWorks, we are 6,000 employees dedicated to improving healthcare together with our customers. More than 150,000 physicians nationwide — and more than 850,000 medical professionals around the globe — rely upon our EHR software for comprehensive clinical documentation, along with solutions for telehealth, Population Health, Patient Engagement, and Revenue Cycle Management. Privately held, and driven by innovation and excellence, we have a single focus — providing our customers with secure, cloud-based solutions to their healthcare IT needs.
Stay up to date with eClinicalWorks. Sign up for our newsletter.
eClinicalWorks | © 2023 All rights reserved | Privacy Policy | Terms of Use | Your Privacy Choices | Benefits Transparency
